Cargando…

Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma

BACKGROUND: Pathologic lymph node staging is becoming a deficient method in the demanding molecular era. Nevertheless, the use of more sensitive molecular analysis for nodal staging is hampered by its high costs and extensive time requirements. Our aim is to take a step forward in colon cancer (CC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakislova, Natalia, Montironi, Carla, Aldecoa, Iban, Fernandez, Eva, Bombi, Josep Antoni, Jimeno, Mireya, Balaguer, Francesc, Pellise, Maria, Castells, Antoni, Cuatrecasas, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237515/
https://www.ncbi.nlm.nih.gov/pubmed/28088238
http://dx.doi.org/10.1186/s12967-016-1114-3
_version_ 1782495541776613376
author Rakislova, Natalia
Montironi, Carla
Aldecoa, Iban
Fernandez, Eva
Bombi, Josep Antoni
Jimeno, Mireya
Balaguer, Francesc
Pellise, Maria
Castells, Antoni
Cuatrecasas, Miriam
author_facet Rakislova, Natalia
Montironi, Carla
Aldecoa, Iban
Fernandez, Eva
Bombi, Josep Antoni
Jimeno, Mireya
Balaguer, Francesc
Pellise, Maria
Castells, Antoni
Cuatrecasas, Miriam
author_sort Rakislova, Natalia
collection PubMed
description BACKGROUND: Pathologic lymph node staging is becoming a deficient method in the demanding molecular era. Nevertheless, the use of more sensitive molecular analysis for nodal staging is hampered by its high costs and extensive time requirements. Our aim is to take a step forward in colon cancer (CC) lymph node (LN) pathology diagnosis by proposing a feasible and efficient molecular method in routine practice using reverse transcription loop-mediated isothermal amplification (RT-LAMP). RESULTS: Molecular detection of tumor cytokeratin 19 (CK19) mRNA with RT-LAMP was performed in 3206 LNs from 188 CC patients using two methods: individual analysis of 1449 LNs from 102 patients (individual cohort), and pooled LN analysis of 1757 LNs from 86 patients (pooling cohort). A median of 13 LNs (IQR 10–18) per patient were harvested in the individual cohort, and 18 LNs (IQR 13–25) per patient in the pooling cohort (p ≤ 0.001). The median of molecular assays performed in the pooling cohort was 2 per patient (IQR 1–3), saving a median of 16 assays/patient. The number of molecular assays performed in the individual cohort was 13 (IQR 10–18), corresponding to the number of LNs to be analyzed. The sensitivity and specificity of the pooling method for LN involvement (assessed by hematoxylin and eosin) were 88.9% (95% CI 56.5–98.0) and 79.2% (95% CI 68.9–86.8), respectively; concordance, 80.2%; PPV, 33.3%; NPV, 98.4%. The individual method had 100% sensitivity (95% CI 72.2–100), 44.6% specificity (95% CI 34.8–54.7), 50% concordance, 16.4% PPV, and 100% NPV. The amount of tumor burden detected in all LNs of a case, or total tumor load (TTL) was similar in both cohorts (p = 0.228). CONCLUSIONS: LN pooling makes it possible to analyze a high number of LNs from surgical colectomies with few molecular tests per patient. This approach enables a feasible means to integrate LN molecular analysis from CC specimens into pathology diagnosis and provides a more accurate LN pathological staging with potential prognostic implications.
format Online
Article
Text
id pubmed-5237515
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52375152017-01-18 Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma Rakislova, Natalia Montironi, Carla Aldecoa, Iban Fernandez, Eva Bombi, Josep Antoni Jimeno, Mireya Balaguer, Francesc Pellise, Maria Castells, Antoni Cuatrecasas, Miriam J Transl Med Methodology BACKGROUND: Pathologic lymph node staging is becoming a deficient method in the demanding molecular era. Nevertheless, the use of more sensitive molecular analysis for nodal staging is hampered by its high costs and extensive time requirements. Our aim is to take a step forward in colon cancer (CC) lymph node (LN) pathology diagnosis by proposing a feasible and efficient molecular method in routine practice using reverse transcription loop-mediated isothermal amplification (RT-LAMP). RESULTS: Molecular detection of tumor cytokeratin 19 (CK19) mRNA with RT-LAMP was performed in 3206 LNs from 188 CC patients using two methods: individual analysis of 1449 LNs from 102 patients (individual cohort), and pooled LN analysis of 1757 LNs from 86 patients (pooling cohort). A median of 13 LNs (IQR 10–18) per patient were harvested in the individual cohort, and 18 LNs (IQR 13–25) per patient in the pooling cohort (p ≤ 0.001). The median of molecular assays performed in the pooling cohort was 2 per patient (IQR 1–3), saving a median of 16 assays/patient. The number of molecular assays performed in the individual cohort was 13 (IQR 10–18), corresponding to the number of LNs to be analyzed. The sensitivity and specificity of the pooling method for LN involvement (assessed by hematoxylin and eosin) were 88.9% (95% CI 56.5–98.0) and 79.2% (95% CI 68.9–86.8), respectively; concordance, 80.2%; PPV, 33.3%; NPV, 98.4%. The individual method had 100% sensitivity (95% CI 72.2–100), 44.6% specificity (95% CI 34.8–54.7), 50% concordance, 16.4% PPV, and 100% NPV. The amount of tumor burden detected in all LNs of a case, or total tumor load (TTL) was similar in both cohorts (p = 0.228). CONCLUSIONS: LN pooling makes it possible to analyze a high number of LNs from surgical colectomies with few molecular tests per patient. This approach enables a feasible means to integrate LN molecular analysis from CC specimens into pathology diagnosis and provides a more accurate LN pathological staging with potential prognostic implications. BioMed Central 2017-01-14 /pmc/articles/PMC5237515/ /pubmed/28088238 http://dx.doi.org/10.1186/s12967-016-1114-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Rakislova, Natalia
Montironi, Carla
Aldecoa, Iban
Fernandez, Eva
Bombi, Josep Antoni
Jimeno, Mireya
Balaguer, Francesc
Pellise, Maria
Castells, Antoni
Cuatrecasas, Miriam
Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
title Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
title_full Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
title_fullStr Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
title_full_unstemmed Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
title_short Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
title_sort lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237515/
https://www.ncbi.nlm.nih.gov/pubmed/28088238
http://dx.doi.org/10.1186/s12967-016-1114-3
work_keys_str_mv AT rakislovanatalia lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT montironicarla lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT aldecoaiban lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT fernandezeva lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT bombijosepantoni lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT jimenomireya lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT balaguerfrancesc lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT pellisemaria lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT castellsantoni lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma
AT cuatrecasasmiriam lymphnodepoolingafeasibleandefficientmethodoflymphnodemolecularstagingincolorectalcarcinoma